Demant A/s · OMXCOP:DEMANT
Demant A/s — Q1 2016 Earnings Presentation
12 slides from Demant A/s's earnings presentation, May 10, 2016
Slide 1: Interim information
Interim information 10 May 2016
Slide 2: Agenda
Agenda ▪ Global hearing aid market ▪ William Demant Holding, Hearing Devices ▪ Launch of Oticon OpnTM ▪ Hearing Implants ▪ Diagnostic Instruments ▪ Group highlights ▪ Outlook 2
Slide 3: Strong unit growth in the global hearing aid market
Global hearing aid market Strong unit growth in the global hearing aid market We estimate that the global unit growth rate was above 4-5% in Q1 2016, with modest growth rates in terms of value US growth driven by Costco and large chains, but also solid Estimated market growth among independents; HIA
Slide 4: Strong unit growth and lower ASPs
William Demant Holding, Hearing Devices Strong unit growth and lower ASPs ▪ Changes in country and channel mix ▪ Europe is main growth driver ▪ Strong export sales ▪ Strong growth in NHS ▪ Stable market share with VA ▪ Fierce competition ▪ Several product introductions among competitors in the high-
Slide 5: Paradigm shift with Oticon Opn
New product launch in Hearing Devices Paradigm shift with Oticon OpnTM ▪ OpenSound paradigm ▪ Making directionality a thing of the past ▪ 20/20/30* documented benefits ▪ New powerful platform ▪ 50x faster than Inium Sense ▪ 64 channels ▪ New TwinLinkTM wireless technology ▪ World’s first low-power d
Slide 6: Growth expectations remain positive
Hearing Implants Growth expectations remain positive ▪ Satisfactory market growth with regional differences ▪ Slow growth in oil-dependent markets ▪ Neuro launch remains a slow process ▪ Training of surgeons ▪ Initial feedback from clinics and surgeons has been very positive ▪ Increased competition
Slide 7: Positioned for growth with new product introductions
Diagnostic Instruments Positioned for growth with new product introductions ▪ Modest growth in slow market ▪ Especially slow in oil-dependent countries ▪ New products introduced at AudiologyNOW! have been well received ▪ Delivery expected to start now and at the beginning of H2 2016 7
Slide 8: Growth in all business activities
Group highlights Growth in all business activities ▪ Revenue growth in all business activities ▪ Strong unit growth and lower ASPs in the wholesale business ▪ Strong growth in the retail business ▪ Diagnostic Instruments and Hearing Implants impacted by oil- dependent countries ▪ 2016 EBIT to be ske
Slide 9: 2016 outlook maintained
Outlook 2016 outlook maintained We expect to see a unit growth rate of 4-5% in the global hearing aid market, which will however be partly offset by a decline in the market’s average selling price due to continued mix shifts and fierce competition. In terms of value, we expect to see a slightly posi
Slide 10: Save the date
Save the date William Demant Capital Market Day 2016 Tuesday and Wednesday 7-8 June 2016 Kongebakken 9 2765 Smørum, Denmark ... details to follow 10
Slide 11: Q&A
QA 11 William Demant / 4
Slide 12: IR contacts
Investors and analysts are welcome to contact IR contacts Søren B. Andersson Rasmus Sørensen Vice President, Investor Relations Investor Relations Officer Tel.: +45 3913 8967 Tel.: +45 3913 7733 Mob.: +45 5117 6657 Mob.: +45 2177 6840 ... by phone +45 3917 7300 or by e-mail to william@demant.com. 12